Axsome Therapeutics, Inc. announced seven presentations at the SLEEP 2025 conference, including two featured oral sessions focused on its investigational drugs AXS-12 and solriamfetol for central ...
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced presentations on Axumin® (fluciclovine F ...
About ELZONRIS® ELZONRIS® (tagraxofusp-erzs), a CD123-directed cytotoxin, is approved by the U.S. Food and Drug Administration (FDA) and commercially available in the U.S. for the treatment of adult ...
The International STAR Registry captures high fidelity data on real-world clinical use and associated clinical outcomes using CytoSorb ® for antithrombotic drug removal (ATR) in the acute hospital ...
Cool cars and funky music, fantastic furniture and out-of-this-world toys are just a few examples of the creative work that went on during the post World War II era. It was a dynamic time in America ...